Internal Medicine, Gastroenterology · Waterville, ME
NPI
1316278898
Since 2010
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
325 Kennedy Memorial Dr
Waterville, ME, 04901
Phone (207) 872-2424
Groups this clinician bills Medicare through
Medicare paid, 2024
$62K
671 services
Medicare patients, 2024
333
Average age 69
Drug cost, 2024
$1.7M
1,410 prescriptions
Company payments, 2025
$221
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sakdhisapol Katanyutanon was code 45380 (lower gi endoscopy - other), 131 times for 130 patients. In total Sakdhisapol Katanyutanon billed 671 services in 32 codes, and Medicare paid $62K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-10-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 45380 Lower GI Endoscopy - Other | Office | 131 | 130 | $35.00 | $4,585 |
| 45385 Colonoscopy - Lesion Removal | Office | 128 | 128 | $166.25 | $21K |
| 43239 Upper GI Endoscopy | Office | 127 | 119 | $58.32 | $7,407 |
| 99214 Office E&M - Established | Office | 40 | 30 | $60.52 | $2,421 |
| G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Office | 26 | 26 | $4.12 | $107 |
| 45390 Lower GI Endoscopy - Other | Office | 25 | 25 | $254.63 | $6,366 |
| 45385 Colonoscopy - Lesion Removal | Facility | 19 | 19 | $156.83 | $2,980 |
| 43249 Upper GI Endoscopy | Office | 17 | 15 | $79.86 | $1,358 |
| 43251 Upper GI Endoscopy | Office | 16 | 15 | $125.39 | $2,006 |
| 43248 Upper GI Endoscopy | Office | 15 | 15 | $97.36 | $1,460 |
| 99223 Hospital E&M - Initial | Facility | 15 | 15 | $128.63 | $1,929 |
| 43239 Upper GI Endoscopy | Facility | 13 | 13 | $60.57 | $787 |
| 43235 Upper GI Endoscopy | Office | 13 | 13 | $85.90 | $1,117 |
| 45380 Lower GI Endoscopy - Other | Facility | 11 | 11 | $24.43 | $269 |
By year: 2022 $61K for 646 services; 2023 $61K for 685 services; 2024 $62K for 671 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sakdhisapol Katanyutanon prescribed most often to Medicare patients was Peg 3350-Electrolyte (Sodium Chloride/Nahco3/Kcl/Peg), with 626 prescriptions and refills. In total Sakdhisapol Katanyutanon wrote 1,410 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Peg 3350-Electrolyte Sodium Chloride/Nahco3/Kcl/Peg | 626 | 626 | 600 | $12K |
| Omeprazole Generic | 104 | 263 | 45 | $1,230 |
| Pantoprazole Sodium Generic | 61 | 167 | 30 | $1,008 |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 59 | 59 | 54 | $1,043 |
| Gavilyte-N Sodium Chloride/Nahco3/Kcl/Peg | 48 | 48 | 48 | $739 |
| Stelara Ustekinumab | 42 | 47 | Under 11 | $1.2M |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 26 | 26 | 26 | $1,560 |
| Mesalamine Generic | 25 | 65 | Under 11 | $17K |
| Ursodiol Generic | 23 | 33 | Under 11 | $7,562 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 23 | 23 | 23 | $330 |
| Linzess Linaclotide | 22 | 63 | Under 11 | $34K |
| Vemlidy Tenofovir Alafenamide | 20 | 20 | Under 11 | $31K |
| Prednisone Generic | 20 | 26 | Under 11 | $111 |
| Spironolactone Generic | 19 | 32 | Under 11 | $225 |
| Esomeprazole Magnesium Generic | 19 | 57 | Under 11 | $1,081 |
Brand drugs: - claims; generic drugs: 1,027 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sakdhisapol Katanyutanon $221 ($221 in general payments such as food, travel and fees) from 4 companies. The largest payer was Janssen Biotech, Inc. with $73.69.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.